About us
iLoF is enabling a new era of personalized medicine, by using AI and photonics to build a cloud-based library of diseases biomarkers and biological profiles, and provide screening and stratification tools in an affordable, fast, portable way.
Selected as the winner of numerous industry awards, iLoF has been featured as one of the most disruptive companies in Europe using Photonics and Artificial Intelligence to solve the biggest healthcare challenges of our time.
Early 2016
Joana Paiva, co-founder and CTO, with Paula Sampaio, co-founder and CSO, recognizes an opportunity to apply photonics and A.I. to detect diseases during her PhD
March 2019
Joana Paiva along with co-founders, Paula Sampaio, Luis Valente and Mehak Mumtaz, begin their ‘Wild Card Journey’, to bring the technology to market
July 2019
August 2019
iLoF is founded and receives its first round of funding from EIT Health
November 2019
iLoF establishes R&D operations at the Medical Faculty, University of Porto, and its commercial operations at the Oxford Foundry, Oxford University’s startup incubator
November 2019
iLoF wins the Altice Innovation Award for startups
March 2020
iLoF named one of the #50GameChangers around Oxford and the Thames Valley UK
March 2020
iLoF research published in Scientific Reports (Nature Publishing)
March 2020
iLoF co-founders named in Forbes’ 30 Under 30 List for Science and Healthcare
March 2020
iLoF is chosen as one of the 10 DeepTech businesses at the Mayor of London’s Techinvest
April 2020
iLof enters Google for Startups UK accelerator program
July 2020